Envestnet Asset Management Inc Acadia Pharmaceuticals Inc Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q4 2024
A detailed history of Envestnet Asset Management Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 106,664 shares of ACAD stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,664
Previous 118,701
10.14%
Holding current value
$1.93 Million
Previous $1.83 Million
7.17%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$775 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$252 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$218 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$157 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$132 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.93B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...